Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Share-based Compensation (IS): 2014-2024

Historic Share-based Compensation (IS) for MediWound (MDWD) over the last 11 years, with Dec 2024 value amounting to $3.1 million.

  • MediWound's Share-based Compensation (IS) rose 64.84% to $844,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $2.7 million, marking a year-over-year increase of 28.26%. This contributed to the annual value of $3.1 million for FY2024, which is 61.75% up from last year.
  • As of FY2024, MediWound's Share-based Compensation (IS) stood at $3.1 million, which was up 61.75% from $1.9 million recorded in FY2023.
  • MediWound's Share-based Compensation (IS)'s 5-year high stood at $3.1 million during FY2024, with a 5-year trough of $1.3 million in FY2020.
  • Over the past 3 years, MediWound's median Share-based Compensation (IS) value was $1.9 million (recorded in 2022), while the average stood at $2.3 million.
  • Per our database at Business Quant, MediWound's Share-based Compensation (IS) declined by 0.31% in 2023 and then soared by 61.75% in 2024.
  • MediWound's Share-based Compensation (IS) (Yearly) stood at $1.3 million in 2020, then grew by 26.55% to $1.7 million in 2021, then climbed by 16.32% to $1.9 million in 2022, then declined by 0.31% to $1.9 million in 2023, then spiked by 61.75% to $3.1 million in 2024.